Virus News and Research

Latest Virus News and Research

mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

4 Apr 2022
The effect of COVID-19 on the lung function of young adults

The effect of COVID-19 on the lung function of young adults

3 Apr 2022
Research demonstrates potential of local siRNA delivery as COVID antiviral therapy in the lung

Research demonstrates potential of local siRNA delivery as COVID antiviral therapy in the lung

3 Apr 2022
An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

An in-depth analysis of pathogenesis of SARS-CoV-2 and therapeutic options for COVID-19

3 Apr 2022
Bats carry some of the most virulent, but not the most dangerous zoonotic viruses

Bats carry some of the most virulent, but not the most dangerous zoonotic viruses

3 Apr 2022
Scientists use new CRISPR gene-editing approach to find paths toward possible HIV cure

Scientists use new CRISPR gene-editing approach to find paths toward possible HIV cure

1 Apr 2022
Groundbreaking collaborative work defines the risk of SARS-CoV-2 variants on immune protection

Groundbreaking collaborative work defines the risk of SARS-CoV-2 variants on immune protection

1 Apr 2022
Tulane researchers show how COVID-19 affects the central nervous system

Tulane researchers show how COVID-19 affects the central nervous system

1 Apr 2022
Study finds COVID-19 convalescent children had more robust humoral immune responses to SARS-CoV-2 than convalescent adults

Study finds COVID-19 convalescent children had more robust humoral immune responses to SARS-CoV-2 than convalescent adults

1 Apr 2022
Scientists evaluate the SARS-CoV-2 neutralizing ability of two-dose BNT162b2 vaccination

Scientists evaluate the SARS-CoV-2 neutralizing ability of two-dose BNT162b2 vaccination

1 Apr 2022
TMPRSS2 inhibitor found to be a novel and effective therapeutic option against pan-variant SARS-CoV-2 infections

TMPRSS2 inhibitor found to be a novel and effective therapeutic option against pan-variant SARS-CoV-2 infections

1 Apr 2022
As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

As US nears 1 million covid deaths, one hard-hit county grapples with unthinkable loss

1 Apr 2022
No evidence of SARS-CoV-2 in the U.K.'s wild deer population

No evidence of SARS-CoV-2 in the U.K.'s wild deer population

31 Mar 2022
NIH program provides a real-time risk assessment of variants of SARS-CoV-2

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

31 Mar 2022
Therapeutic antibodies against filoviruses including Ebola and Marburg

Therapeutic antibodies against filoviruses including Ebola and Marburg

31 Mar 2022
Potential new approach could make Japanese encephalitis vaccine more affordable

Potential new approach could make Japanese encephalitis vaccine more affordable

31 Mar 2022
The longest duration of SARS-CoV-2 positivity after initial diagnosis

The longest duration of SARS-CoV-2 positivity after initial diagnosis

31 Mar 2022
The mucosal antibody response to SARS-CoV-2

The mucosal antibody response to SARS-CoV-2

31 Mar 2022
How effective are household cleaning agents against SARS-CoV-2?

How effective are household cleaning agents against SARS-CoV-2?

31 Mar 2022
The evolution of the SARS-CoV-2 spike protein

The evolution of the SARS-CoV-2 spike protein

31 Mar 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback